PW
ABMD

Price Wealth’s Abiomed Inc ABMD Stock Holding History

Price Wealth’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2K Hold
7
– – ﹤0.01% 402
2020
Q2 		$2K Buy
+7
New +$1.41K ﹤0.01% 323
2020
Q1 		– Sell
-8
Closed -$1K – 522
2019
Q4 		$1K Buy
+8
New +$1.48K ﹤0.01% 391
2018
Q3 		– Sell
-9
Closed -$4K – 454
2018
Q2 		$4K Buy
+9
New +$3.26K ﹤0.01% 398

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Price Wealth's ABMD Position: Q3 2020 in Review

Price Wealth held its Abiomed Inc (ABMD) position steady in Q3 2020 at 7 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Price Wealth first reported a position in ABMD in Q2 2018 and has held it in 4 quarters since. The position peaked at $4K in Q2 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Price Wealth held 7 shares of Abiomed Inc worth $2K as of Q3 2020.
  • Price Wealth left its Abiomed Inc share count unchanged in Q3 2020.
  • Abiomed Inc made up ﹤0.01% of Price Wealth's portfolio in Q3 2020, its #402 holding.
  • Price Wealth first reported a position in Abiomed Inc in Q2 2018 and has held it in 4 quarters since.
  • Price Wealth's Abiomed Inc position peaked at $4K in Q2 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.